Introduction

Complications following total knee arthroplasty (TKA) lead to high patient morbidity and markedly increased healthcare costs. Periprosthetic joint infections, for example, typically require multiple surgical revisions, prolonged antibiotic therapy, and occasionally amputation [1]. The treatment of an infected total knee implant costs 3 to 4 times that of an uncomplicated primary TKA [2]. Much work has been invested in discovering prognostic biomarkers that predict postoperative complications early in their course.

The acute phase response (APR) is the body’s response to tissue injury. Cytokines are released at the site of tissue injury and travel to the liver and other organs where thousands of genes are regulated to produce proteins that aid in tissue survival and regeneration [3, 4]. Therefore, acute phase reactants in circulation are sensitive, albeit nonspecific, laboratory measures indicating tissue injury. Studies have shown that C-reactive protein (CRP) and fibrinogen levels rise rapidly with the onset of tissue damage, with CRP falling rapidly following injury resolution and fibrinogen showing a more prolonged descent to baseline value [5–7]. CRP levels remain elevated in the face of repeated tissue injury and therefore can be utilized as a marker of injury duration [8]. Prior studies have demonstrated the clinical utility of serially assessing CRP following surgeries, such as total joint arthroplasties, to predict patient outcomes and assess the risk of complications [9, 10].

While most plasma acute phase reactants increase in response to injury, the concentration of several reactants decreases following tissue injury. These proteins are referred to as negative acute phase reactants. Albumin is a known negative acute phase reactant that decreases in response to physiologic stress. Clinically, albumin levels are often used as a serologic marker of nutritional status, with low albumin levels representing malnutrition, although several studies have shown that albumin is an inconsistent measure of nutritional status [11–14]. Furthermore, decreased albumin levels are predictive of morbidity and mortality postoperatively, as well as in disease states such as cirrhosis, renal failure, burns, malignancy, and autoimmune disorders [15–23]. Similarly, Huang et al and others have demonstrated that preoperative hypoalbuminemia, defined as an albumin level less than 3.5 g/dL, correlates with postoperative complications in patients undergoing a TKA [24–27]. While these studies illustrates the potential clinical values for measuring albumin preoperative, the value of longitudinal measure of albumin following TKA to predict patient outcomes from surgery or complications remains unknown.

While individual serologic measures of the APR can prognosticate disease severity and patient outcomes, recent studies have begun to demonstrate the improved predictive capacity of combinatory measures. For example, the fibrinogen to albumin ratio (FAR) has been demonstrated to significantly correlate with poorer survival and negative outcomes in patients suffering from cancer or cardiovascular disease [28–33]. To date, limited investigations in the orthopaedic space have reported on the clinical utility of serial measures of either albumin or FAR. Therefore, the purpose of this study was to describe the normal course of albumin and FAR in healthy patients following TKA, relative to the course of known plasma acute phase reactants, CRP, and fibrinogen. Secondarily, this study will examine if the variance in preoperative albumin or FAR correlates with patient comorbidities, as measured by the Charlson comorbidity index (CCI). We postulate that albumin levels and FAR will follow a defined and predictable course following acute surgical intervention. Secondarily, we hypothesize that CCI will positively correlate with preoperative FAR.

Material and methods

Results

One hundred ninety-nine total patients underwent primary TKA during the time period of the study. One hundred sixty-five patients were included in the study, including 62 males and 103 females. The average age of all patients was 64.7 years (range: 35.5–89.7 years). The average age-adjusted Charlson Comorbidity Index of all patients was 2.19 (Table 1). The average estimated blood loss during the surgery within this cohort was 142.7 mL, with an average change in hemoglobin from the preoperative period to POD0 of 13.1% or 17.2% by POD1.

Table 1

Demographics of patients included in the study.

Characteristic	TKA (n = 165)
Age at time of surgery (y), mean (range)	64.7 (35.5–89.7)
Male, n (%)	62 (37.6)
Age-adjusted CCI, mean (SD)	2.19 (2.13)

All patients underwent a primary TKA and had an uncomplicated postoperative course. SD, standard deviation.

CRP

The median preoperative CRP value was 3.4 mg/L, which increased to 153.0 mg/L on POD3. The CRP value nearly returned to baseline (median 12.8 mg/L) by postoperative week 2 and was entirely within normal limits by postoperative week 6 (median 4.0 mg/L) (Fig 1, Table 2).

Fig 1

Median circulating albumin (blue circle) and CRP (red square) following TKA. Y-error bars depict a CI of 95%. r = -0.41.

Table 2

Circulating acute phase reactants following TKA.

	Pre-Op	POD0	POD1	POD2	POD3	2-week	6-week
Albumin (g/dL)	4.3 (4.1–4.5), 150n	3.8 (3.6–3.9), 29n	3.6 (3.4–3.7), 29n	-	-	4.0 (3.9–4.2), 46n	4.3 (4.0–4.4), 55n
CRP (mg/L)	3.4 (1.5–6.9), 157n	4.7 (1.9–9.3), 126n	8.6 (4.8–16.0), 157n	99.4 (60.4–144.0), 132n	153.0 (96.8–187.7), 52n	12.8 (6.7–29.3),	4.0 (2.5–8.5), 99n
Fibrinogen (mg/dL)	386 (333–443), 155n	345 (305–396), 126n	340 (299–392), 157n	480 (424–548), 127n	579 (516–654), 52n	522 (457–601), 125n	391 (355–452), 97n
FAR (g/L)	0.087 (0.076–0.105), 139n	0.099 (0.083–0.113), 29n	0.099 (0.087–0.116), 28n	-	-	0.130 (0.116–0.153), 34n	0.098 (0.086–0.111), 29n

Values presented as median (25^th-75^th interquartile range).

Fibrinogen

Fibrinogen is a long-acting plasma acute phase reactant, with a longer elevation in levels following iatrogenic injury. The median preoperative fibrinogen value was 386 mg/dL, which increased to 579 mg/dL on POD3. The fibrinogen value remained elevated (median 522 mg/dL) at postoperative week 2 but returned to baseline by postoperative week 6 (median 391 mg/dL) (Fig 2A, Table 2).

Fig 2

A) Median circulating albumin (blue circle) and fibrinogen (green square) following TKA. r = 0.29. B) Median fibrinogen/albumin ratio (FAR) following TKA. Y-error bars depict a CI of 95%.

Case examples of variance

To identify the normal albumin and FAR course following primary TKA, patients with chronic conditions or those undergoing TKA revisions were excluded from this study. In patients excluded, we observed significantly greater preoperative CRP and FAR in patients with either a chronic inflammatory condition (rheumatoid arthritis) or those necessitating a revision TKA for a periprosthetic infection (Fig 3A). Yet, no significant difference in age-adjusted CCI was observed between included patients and excluded patients (p>0.05).

Fig 3

A) Comparison of preoperative CRP and fibrinogen/albumin ratio (FAR) in included study patients (N = 157) and those excluded for rheumatoid arthritis (N = 9) or necessitating a revision TKA due to periprostatic infection (n = 32). Whiskers represent the range of data. Cohorts were compared using a non-parametric ANOVA (Kruskal Wallis test) given that data was nonnormally distributed, α = 0.05. B) Median circulating albumin (blue) and CRP (red) following TKA in a patient with cirrhosis who developed wound dehiscence at postoperative week 2. Y-error bars depict a CI of 95%.

A further example of the variation of the APR following primary TKA was observed in a patient excluded from our study due to the occurrence of a postoperative complication. This patient had advanced cirrhosis with a preoperative albumin level of 2.8 g/dL, a preoperative CRP value of 29.7 mg/L, and a FAR of 0.124 g/L, indicating end-stage disease with a low hepatic synthetic capacity. On POD1, the albumin level decreased 17.8%, to a value of 2.2 g/dL, resulting in a reduced FAR of 0.084 g/L; while the CRP value decreased to 2.5 mg/L (Fig 3B). The CRP value increased dramatically to 45 mg/L at 2 weeks postoperative when the patient presented with wound dehiscence and persistent serous drainage from the surgical incision that ultimately required surgical revision. The patient’s albumin and FAR level remained depressed throughout the postoperative course.

Discussion

Through serial measures, our data demonstrated that albumin levels decline acutely following TKA, with levels reaching a trough on POD1 and recovering by 6 weeks postoperative. We also have shown that CRP and fibrinogen values increase following TKA and reach a peak on POD3. CRP levels return to baseline by 2 weeks postoperative while fibrinogen levels remain elevated until 6 weeks postoperative. Aligning with the changes in fibrinogen, FAR remains consistent through POD1, but is markedly increased by 2 weeks postoperative with resolution by 6 weeks postoperative. Thus, the course of CRP closely mirrors that of albumin, although CRP production is upregulated while albumin production is downregulated (Fig 1, Table 2). Finally, assessment of excluded patients suggests that elevated preoperative FAR or a persistent depression of albumin outside of the expected time course may be associated with patient comorbidities or complications.

The progression of CRP has been well characterized following total joint arthroplasty and has been shown to follow a predictable course [6]. Persistent elevation in CRP outside of the normal time course is associated with complications, such as periprosthetic infections [34]. Defining the normal course of CRP following arthroplasty has allowed physicians to routinely trend values postoperatively to assess for persistent elevations suggestive of postoperative complications. We have demonstrated that albumin levels similarly have a predictable postoperative course following TKA across 165 patients. Therefore, future studies are warranted to determine whether derangements of albumin or FAR from this natural course are predictive of postoperative complications.

The physiologic role of albumin is multifaceted and includes binding and transporting fatty acids, ions, and amino acids along with maintaining colloid osmotic pressure [15, 18, 35]. Albumin has also been shown to scavenge free radicals and to inhibit platelet function and thrombosis [15]. Synthesis is primarily regulated by colloid osmotic pressure and the osmolality of the extravascular space although growth factors such as insulin, cortisol, and thyroxine stimulate its synthesis [15, 36]. Albumin catabolism occurs primarily in the vascular endothelium and the metabolic half-life of albumin is 17–19 days [15, 18]. Changes in albumin levels have long been attributed to changes in nutritional status. In rats and rabbits, fasting for both short and prolonged periods of time are associated with decreased albumin synthesis within hepatocytes [37–39]. Albumin synthesis declines by 53% in well-perfused hepatocytes in rabbits following an 18–36 hour fast [37]. However, several studies have determined that serum albumin is not a consistent marker of nutritional status in humans. Smale et al demonstrated that serum albumin levels in humans remain constant following a 7-day fast [40]. Similarly, a recent study has also shown that albumin levels do not correlate with lean mass, appendicular skeletal mass, or body mass index in the elderly population [11].

The relationship between albumin and malnutrition becomes further complicated in patients with end-stage organ disease or chronic inflammatory conditions. In patients with end stage renal disease, both malnutrition and inflammation lead to hypoalbuminemia [12, 41]. These processes are intricately linked, as several acute phase reactants both suppress appetite and increase protein catabolism [16]. Studies have shown that CRP values and the normalized protein catabolic rate, which represents nutritional status, inversely correlate with serum albumin concentrations [12]. Furthermore, IL-6 has been shown to directly reduce the expression of albumin mRNA in hepatocytes [15]. Thus, in patients with end-stage organ disease, hypoalbuminemia may represent a chronic inflammatory state compounded by malnutrition.

Several studies have shown that decreased albumin is not only predictive of mortality and complications in critically ill patients but also that preoperative and postoperative albumin levels correlate with postoperative complications. One study demonstrated that albumin levels decline as early as 6 hours postoperatively following intraabdominal procedures and that the decrease in albumin correlated with both length of hospital stay and postoperative complications [21]. Ryan et al demonstrated that a postoperative albumin level lower than 2 g/L correlated with a two-fold risk of a significant postoperative complication following esophagectomy [23]. Our data demonstrates that, compared to preoperative values, albumin levels drop 17.5% on the first postoperative day following a TKA. This temporal relationship is critical, as healthy patients undergoing significant procedures, such as a TKA, can experience a decline in albumin concentration following injury. This suggests that depression in albumin levels following an injury are not specifically associated with a change in nutritional status; rather, they are a normal response to tissue injury and repair.

In addition to the numerous studies assessing changes in single acute phase reactants relative to disease progression, recent studies in critically ill patients, cardiovascular medicine, and oncology have likewise begun to examine the prognostic value of ratioed measures, such as CRP/albumin and fibrinogen/albumin. Park et. al. demonstrated that CRP/albumin ratios performed better than CRP alone for predicting mortality in critically ill ICU patients [42]. Likewise, Hwang et. al. and others have illustrated that FAR has improved prognostic capacity over that of a single marker for prognosis [28] and overall survival of cancer patients [29–31]. To date, few studies have examined ratioed measures of acute phase reactants, such as FAR, in orthopaedic patients. A recent study by Liu et. al. is one of the first to examine FAR in pathology affecting the musculoskeletal system, where FAR was found to increase in patients with ankylosing spondylitis relative to disease severity [43]. This present study aimed at defining the normal albumin and FAR course following TKA in healthy patients. Aligning with changes in fibrinogen, FAR peaked by 2 weeks and resolved by 6 weeks postoperatively. In patients excluded due to comorbidities or complications, we observed a significant elevation in the preoperative FAR as well as deviation from the normal course. Future studies are warranted to determine whether derangements of FAR from expected preoperative values or the postoperative course are predictive of postoperative complications following orthopaedic surgeries.

The Charlson comorbidity index (CCI) was developed to objectively estimate a patient’s 1-year mortality rates based on preexisting comorbidities [44, 45]. From this initial study, the CCI has been broadly applied across medicinal specialties to predict patient outcomes following interventions. While studies have found that CCI positively predicts patient outcomes following the medical intervention [46–50], studies have likewise reported that CCI had poor or no predictive capacity for patient outcomes or disease severity [51–55]. This present study found that a very weak positive correlation between age-adjusted CCI and pre-operative FAR, yet no correlation between age-adjusted CCI and preoperative CRP. Furthermore, there were no significant differences in age-adjusted CCI between patients included and those excluded for rheumatoid arthritis or revision surgery due to infection; although the risk for complications was higher amongst the excluded patients [56–58]. Together, this data aligns with recent reports suggesting that CCI may not be a sensitive predictor to patient postoperative outcomes following primary total joint arthroplasty [53]. Given the preoperative variance in CRP and FAR between included and excluded patient cohorts, future prospective studies are warranted to examine the positive predictive capacity of preoperative CRP and FAR to predict adverse postoperative outcomes.

This study had several limitations that influence the interpretation of the results. Changes in albumin following surgical procedures may be due to several factors including inflammation, hypermetabolism, redistribution of albumin to the extravascular compartment, changes in colloid osmotic pressure, or blood loss with subsequent hemodilution [15, 18]. The largest confounder in our study is intraoperative blood loss with subsequent fluid repletion and hemodilution. The average change in hemoglobin levels within the albumin cohort from the preoperative period to POD1 closely mirrored the average change in albumin, indicating that hemodilution may play a significant role in the decline in albumin levels we observed. However, several studies have demonstrated similar declines in albumin concentration without significant blood loss and hemodilution. Analysis of decreased albumin values following uncomplicated aortic surgery demonstrated that 18% of the decline in albumin was attributable to blood loss, 6% was attributable to catabolism, and 77% was attributable to redistribution in the extravascular space [59]. Furthermore, regardless of the cause of the convalescent change in albumin, it is clear that the postoperative change in albumin closely mirrors that of CRP, highlighting its role in the acute phase response. Another limitation of this study is that there were limited data points to describe albumin, and thus FAR, on POD2 and POD3. Further large-scale studies are warranted to further characterize the full time course of albumin and FAR in the postoperative setting and the overall clinical utility of these measures to predict patient outcomes.

Conclusions

This study demonstrates that albumin levels decline rapidly in healthy patients following TKA. Although preoperative albumin levels are predictive of postoperative complications [24], postoperative hypoalbuminemia occurs normally following TKA and follows a predictable postoperative course that mirrors the course of CRP. Elevations in preoperative CRP and FAR are associated with patient statuses more prone to postoperative complications. Therefore, further studies are warranted to determine if persistent depressions of albumin levels or elevated FAR outside of the predictable postoperative course are likewise indicative of complications. Given the low cost and availability of albumin measurement, albumin, and albumin-based ratios such as FAR may be useful serologic measures for monitoring patients’ plasma APR following surgery.